NHS Expands Life-Extending Prostate Cancer Drug Access
Thousands of men in England with non-metastatic prostate cancer will soon receive the life-extending drug abiraterone on the NHS, widening access to vital treatment.
Thousands of men in England with non-metastatic prostate cancer will soon receive the life-extending drug abiraterone on the NHS, widening access to vital treatment.